Join Now

Utah Life Sciences Companies' COVID-19 News

January 8, 2021
Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products

Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly revenue for the company is anticipated to be the highest in the company’s history and to surpass analyst estimates. Analysts’ estimates for the fourth quarter ranged from $24 million to $25.98 million. Quarterly revenue is anticipated to […]

January 8, 2021
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited;  Provides Corporate Update

Clene Nanomedicine, Inc. (Clene) last week announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”) and provided a corporate update. Proceeds from this transaction totaled approximately $31.9 million. The combined, publicly traded company is operating under the name Clene Inc., and its common stock began trading on the NASDAQ Capital Market on […]

January 8, 2021
Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

Kidney care innovators Renalytix AI and DaVita are partnering on a new program aimed at slowing disease progression and improving health outcomes for the nation’s estimated 37 million adults with chronic kidney disease (CKD). This first of its kind program is expected to improve patient outcomes and provide meaningful cost reductions for healthcare providers and […]

December 31, 2020
Co-Diagnostics Designs Test to Detect Mutations for New Coronavirus Strain Using CoPrimer™ Platform

Co-Diagnostics has announced that it has completed principal design work for a PCR test that would allow researchers to identify certain mutations in a newly detected variant of SARS-CoV-2 known as VUI 202012/01. The new coronavirus strain comprises several mutations and may be more contagious than its predecessors. London and the southeast of Great Britain […]

December 31, 2020
Vertex Announces FDA Approvals for Expanded Use of Cystic Fibrosis Medicines 

Vertex has announced FDA approval of eligibility for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include people with cystic fibrosis (CF) ages 12 years and older with certain mutations in the CFTR gene. SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) and KALYDECO® (ivacaftor) also received approvals to include additional responsive mutations in people with CF ages 6 years and older and age 4 […]

December 31, 2020
Phoenix PharmaLabs Announces New Investment Offering with Netcapital

Phoenix PharmaLabs (Phoenix), a Utah company developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced it has launched its second offering campaign on the Netcapital platform. This new offering follows a fund raise in 2019 of more than $1.1 million via Netcapital.  Proceeds from this latest campaign will further support the development […]

December 23, 2020
Medsential Offering an FDA EUA Approved COVID Point of Care Antibody Rapid Test

Medsential has announced that it is now offering COVID-19 IgM/IgG rapid antibody tests to point of care providers and is able to meet high demand. The test has recently received FDA emergency use authorization. “We are thrilled to have a point of care rapid antibody test now available. We know hospitals, medical offices, and other […]

December 23, 2020
ELITech’s COVID, Flu, RSV Multiplex Test Receives CE Mark

ELITech Group recently announced its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been released. The test kit was developed to distinguish SARS-CoV-2 from other respiratory viruses, including influenza A/B and respiratory syncytial virus types A/B that may have similar symptoms. It runs on the firm’s Elite InGenius platform, as well as other […]

December 4, 2020
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test

Co-Diagnostics announced November 25 that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its Saragene™ COVID-19 2-gene multiplex RT-PCR test. Dwight Egan, CEO of Co-Diagnostics, said “tests built on […]

December 4, 2020
Braveheart Brings Healthcare to India’s Last Mile Community

These days we can all use uplifting news, so please check out this short story about how BraveHeart technology is harnessing AI to bridge India’s healthcare divide. iKures, an Indian healthcare company, is equipping community workers in remote areas of the country with BraveHeart portable devices to measure blood pressure, hemoglobin levels, or heart rates […]

November 24, 2020
Milken Institute Ranks Utah Sixth in Nation for Innovation Capacity

The Milken Institute 2020 State Technology and Science Index ranks Utah #6 in the nation for its knowledge economy and capacity for innovation – same ranking as last year. The index, published annually, compares each state’s capacity for achieving prosperity through scientific discovery and technological innovation, by analyzing their performance on a number of key […]

November 13, 2020
Utah Life Sciences Leaders Honored At 2020 Virtual Life Sciences Summit

On the last day of the Summit, BioUtah announced its 2020 Utah Life Sciences award winners, which were presented during a special virtual awards session. Gary Crocker, president of Crocker Ventures, was honored with a Lifetime Achievement Award Other distinguished award winners include Salt Lake City Mayor Erin Mendenhall; Chris Gibson, CEO, Recursion Pharmaceuticals; Randy Rasmussen, co-founder, […]

November 13, 2020
Quansys Biosciences Receives EUA for COVID-19 Antibody Test, Provides Exceptional Clinical Performance

Quansys Biosciences has received  emergency use authorization (EUA) from the FDA for its COVID-19 antibody test. The test allows simultaneous detection of human antibodies to the SARS-CoV-2 S1 protein and the SARS-CoV-2 S2 protein, which has shown measurable improvement in clinical performance, compared to tests using a single protein. “This is very welcome news, said […]

November 13, 2020
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors.  “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]

November 13, 2020
BioHive Launched at Utah Life Sciences Summit – Join the Campaign 

  The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the physical distance, the ULSS made news and ignited our life sciences industry with a special announcement — the launch of BioHive, a new bold campaign to brand and expand Utah’s life sciences ecosystem. ICYMI…view the video and see […]